ANVS
Price
$1.12
Change
-$0.07 (-5.88%)
Updated
Sep 11 closing price
Capitalization
47.72M
60 days until earnings call
Intraday BUY SELL Signals
JAZZ
Price
$245.80
Change
+$5.32 (+2.21%)
Updated
Sep 11 closing price
Capitalization
15.96B
60 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ANVS vs JAZZ

ANVS vs JAZZ Comparison Chart in %
View a ticker or compare two or three
VS
ANVS vs. JAZZ commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANVS is a Hold and JAZZ is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JAZZ($16B) has a higher market cap than ANVS($47.7M). JAZZ YTD gains are higher at: 44.588 vs. ANVS (-67.630). JAZZ has higher annual earnings (EBITDA): 1.62B vs. ANVS (-49.53M). JAZZ has more cash in the bank: 2.2B vs. ANVS (18.7M). JAZZ has higher revenues than ANVS: JAZZ (4.6B) vs ANVS (0).
ANVSJAZZANVS / JAZZ
Capitalization47.7M16B0%
EBITDA-49.53M1.62B-3%
Gain YTD-67.63044.588-152%
P/E RatioN/A16.83-
Revenue04.6B-
Total Cash18.7M2.2B1%
Total DebtN/A4.41B-
FUNDAMENTALS RATINGS
ANVS vs JAZZ: Fundamental Ratings
ANVS
JAZZ
OUTLOOK RATING
1..100
5226
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
76
Overvalued
PROFIT vs RISK RATING
1..100
10033
SMR RATING
1..100
10044
PRICE GROWTH RATING
1..100
9140
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ANVS's Valuation (66) in the null industry is in the same range as JAZZ (76) in the Pharmaceuticals Other industry. This means that ANVS’s stock grew similarly to JAZZ’s over the last 12 months.

JAZZ's Profit vs Risk Rating (33) in the Pharmaceuticals Other industry is significantly better than the same rating for ANVS (100) in the null industry. This means that JAZZ’s stock grew significantly faster than ANVS’s over the last 12 months.

JAZZ's SMR Rating (44) in the Pharmaceuticals Other industry is somewhat better than the same rating for ANVS (100) in the null industry. This means that JAZZ’s stock grew somewhat faster than ANVS’s over the last 12 months.

JAZZ's Price Growth Rating (40) in the Pharmaceuticals Other industry is somewhat better than the same rating for ANVS (91) in the null industry. This means that JAZZ’s stock grew somewhat faster than ANVS’s over the last 12 months.

JAZZ's P/E Growth Rating (100) in the Pharmaceuticals Other industry is in the same range as ANVS (100) in the null industry. This means that JAZZ’s stock grew similarly to ANVS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ANVSJAZZ
RSI
ODDS (%)
Bullish Trend 1 day ago
77%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
63%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
57%
MACD
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
53%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
54%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
56%
Advances
ODDS (%)
Bullish Trend 25 days ago
79%
Bullish Trend 10 days ago
62%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 5 days ago
54%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
70%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
55%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (ANVS: $1.12 vs. JAZZ: $245.80)
Brand notoriety: ANVS and JAZZ are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANVS: 210% vs. JAZZ: 58%
Market capitalization -- ANVS: $47.72M vs. JAZZ: $15.96B
ANVS [@Biotechnology] is valued at $47.72M. JAZZ’s [@Biotechnology] market capitalization is $15.96B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANVS’s FA Score shows that 0 FA rating(s) are green while JAZZ’s FA Score has 1 green FA rating(s).

  • ANVS’s FA Score: 0 green, 5 red.
  • JAZZ’s FA Score: 1 green, 4 red.
According to our system of comparison, JAZZ is a better buy in the long-term than ANVS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANVS’s TA Score shows that 4 TA indicator(s) are bullish while JAZZ’s TA Score has 4 bullish TA indicator(s).

  • ANVS’s TA Score: 4 bullish, 6 bearish.
  • JAZZ’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, JAZZ is a better buy in the short-term than ANVS.

Price Growth

ANVS (@Biotechnology) experienced а -19.42% price change this week, while JAZZ (@Biotechnology) price change was -0.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

ANVS is expected to report earnings on Nov 11, 2026.

JAZZ is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
ANVS
Daily Signal:
Gain/Loss:
JAZZ
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DDVCX12.870.12
+0.94%
Nomura Value C
TWEAX9.360.04
+0.43%
American Century Equity Income A
SSMAX10.77N/A
N/A
SEI Small/Mid Cap Equity A (SIIT)
ARAGX10.10N/A
N/A
Aristotle Growth Equity A
VDMAX11.45N/A
N/A
Virtus KAR Developing Markets A

ANVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANVS has been loosely correlated with ADXN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ANVS jumps, then ADXN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANVS
1D Price
Change %
ANVS100%
-5.88%
ADXN - ANVS
43%
Loosely correlated
+2.95%
JAZZ - ANVS
38%
Loosely correlated
+2.21%
MDGL - ANVS
36%
Loosely correlated
+0.26%
AMLX - ANVS
34%
Loosely correlated
-1.46%
RXRX - ANVS
34%
Loosely correlated
+1.27%
More

JAZZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, JAZZ has been loosely correlated with ZYME. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if JAZZ jumps, then ZYME could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JAZZ
1D Price
Change %
JAZZ100%
+2.21%
ZYME - JAZZ
50%
Loosely correlated
-0.74%
AMLX - JAZZ
43%
Loosely correlated
-1.46%
CLDX - JAZZ
39%
Loosely correlated
-3.15%
JBIO - JAZZ
39%
Loosely correlated
-6.53%
DYN - JAZZ
36%
Loosely correlated
-1.14%
More